Literature DB >> 17457695

Effects of a fat load and exercise on asymptomatic VLCAD deficiency.

U Spiekerkoetter1.   

Abstract

The patient was identified via family screening at the age of 3 years when very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency was diagnosed in his sister by newborn screening. Enzyme and molecular analyses confirmed VLCAD-deficiency (VLCADD). Until the age of 8 years no severe illnesses occurred and the patient was completely asymptomatic without a fat-reduced and fat-modified diet. On regular follow-up, creatine kinase (CK) and liver transaminases were always in the normal range. A long-chain fat load with 1.5 g/kg body weight did not result in clinical symptoms, nor in elevation of CK or liver transaminases. At the age of 8 years, the patient for the first time complained of recurrent muscle pain after exercise. CK concentrations were elevated up to 20,000 U/L during one of these episodes. Medium-chain fat was supplemented. With a medium-chain fat-rich meal directly before exercise, muscle pain after exercise clearly decreased. In asymptomatic mild VLCADD, a fat-reduced diet may not be necessary, whereas in later infancy and adolescence, strenuous physical exercise may require additional energy from medium-chain fat.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457695     DOI: 10.1007/s10545-007-0548-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

Review 1.  Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.

Authors:  Ute Spiekerkoetter; Philip A Wood
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

2.  The effects of aerobic interval training on the left ventricular morphology and function of VLCAD-deficient mice.

Authors:  Charles E Riggs; Marcos A Michaelides; Koulla M Parpa; Nancy J Smith-Blair
Journal:  Eur J Appl Physiol       Date:  2010-07-17       Impact factor: 3.078

3.  Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop.

Authors:  U Spiekerkoetter; M Lindner; R Santer; M Grotzke; M R Baumgartner; H Boehles; A Das; C Haase; J B Hennermann; D Karall; H de Klerk; I Knerr; H G Koch; B Plecko; W Röschinger; K O Schwab; D Scheible; F A Wijburg; J Zschocke; E Mayatepek; U Wendel
Journal:  J Inherit Metab Dis       Date:  2009-04-28       Impact factor: 4.982

Review 4.  Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Kenji Yamada; Takeshi Taketani
Journal:  J Hum Genet       Date:  2018-11-06       Impact factor: 3.172

5.  Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.

Authors:  Sonja Primassin; Sara Tucci; Diran Herebian; Annette Seibt; Lars Hoffmann; Frank ter Veld; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2010-05-06       Impact factor: 4.982

Review 6.  Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.

Authors:  Sara Tucci
Journal:  J Inherit Metab Dis       Date:  2017-02-28       Impact factor: 4.982

7.  Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop.

Authors:  U Spiekerkoetter; M Lindner; R Santer; M Grotzke; M R Baumgartner; H Boehles; A Das; C Haase; J B Hennermann; D Karall; H de Klerk; I Knerr; H G Koch; B Plecko; W Röschinger; K O Schwab; D Scheible; F A Wijburg; J Zschocke; E Mayatepek; U Wendel
Journal:  J Inherit Metab Dis       Date:  2009-04-29       Impact factor: 4.982

8.  Very long-chain acyl-CoA dehydrogenase deficiency: the effects of accidental fat loading in a patient detected through newborn screening.

Authors:  C Ficicioglu; C Hussa
Journal:  J Inherit Metab Dis       Date:  2009-04-04       Impact factor: 4.982

9.  Very long-chain acyl-CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics.

Authors:  David Olsson; Michela Barbaro; Charlotte Haglind; Maria Halldin; Svetlana Lajic; Sara Tucci; Rolf H Zetterström; Anna Nordenström
Journal:  JIMD Rep       Date:  2022-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.